药物发现
药品
医学
范围(计算机科学)
分子药理学
药理学
计算生物学
生物信息学
计算机科学
内科学
生物
受体
程序设计语言
出处
期刊:Frontiers in cardiovascular drug discovery
日期:2022-03-11
被引量:2
标识
DOI:10.2174/97898150369091220601
摘要
Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology. Volume 6 covers the following topics: - Cardiovascular effects of ranolazine and the scope for translational research: a current review of literature - Rho/Rho kinase signaling pathway and disease: - Hibernation or transformation? Challenges in cardiovascular drug development - New approaches in P2Y12 receptor blocker drugs use - Pathophysiological links between diabetes and cardiovascular diseases: at the biochemical and molecular levels
科研通智能强力驱动
Strongly Powered by AbleSci AI